Home › Atrial Fibrillation › NCT05826665
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
Who can join
Ages 18 to 80 · All sexes
Full eligibility criteria
Inclusion Criteria: * Indication for ablation of persistent AF * Age \>18 years * Persistent AF \>7 days and total continuous duration \<2 years * Patients have previously undergone pulmonary vein isolation, using any technique and have had AF recurrence. * Patients have limited additional ablation at their first procedure (e.g. right atrial flutter line). Exclusion Criteria: * Patients with previous ablation in more than one region of the left atrium in addition to the pulmonary veins. * Patients with longstanding persistent AF (continuous duration \>2 years) or significant substrate (mitral valve disease, scarring, very dilated atria \>50mm). * Creatinine clearance estimated glomerular filtration rate (eGFR) \<30mls/min * Contraindication to anticoagulation
About the study
STAR Apollo Mapping System is an FDA cleared mapping technology that can analyze the signals collected during the ablation procedure on the 3D mapping system and give the physician further insight into the AF activation patterns which may assist them in identifying areas responsible for maintaining Atrial Fibrillation (AF). The STAR Apollo Mapping System system allows clinicians, after treating the Pulmonary Veins (PV), to collect data from the atria during clinical AF procedures using standard FDA cleared catheters and devices. This study aims to examine the impact of the STAR Apollo Mapping System on procedural and acute outcomes in a multicenter observational study.
What is being tested
- Persistent AF ablation assisted with the STAR Apollo Mapping System (other)
Sponsor: Kansas City Heart Rhythm Research Foundation · Participants: 200 · Started: Oct 2, 2023
Contact the study team
- Donita Atkins · Phone: 816-651-1969
Official record on ClinicalTrials.gov — NCT05826665
Locations in the U.S.
| Arkansas | St.Bernards Medical Center, Jonesboro (Not yet recruiting) |
| Florida | Sarasota Medical Center, Sarasota |
| Kansas | Kansas City Heart Rhythm Institute - Roe Clinic, Overland Park (Not yet recruiting) Overland Park Regional Medical Center, Overland Park |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.